{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T14:13:50Z","timestamp":1788358430093,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Maternal chorioamnionitis (mCA) and intra-amniotic infection\/inflammation (Triple I) are major causes of fetal inflammatory injury and are associated with preterm birth, white matter injury, cerebral palsy, bronchopulmonary dysplasia (BPD), and necrotising enterocolitis (NEC). No established therapy directly targets the inflammatory and oxidative pathways underlying fetal neuroinjury. N-acetylcysteine (NAC), a glutathione precursor with antioxidant and anti-inflammatory properties, has emerged as a potential adjunctive neuroprotective therapy, although human evidence remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate fetal and neonatal outcomes associated with antenatal or intrapartum NAC administration in pregnancies complicated by mCA or Triple I.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted using MEDLINE, Embase, Cochrane CENTRAL, and ClinicalTrials.gov from inception to December 23, 2025. Eligible studies included randomised controlled trials, prospective cohorts, non-randomised studies, and translational animal models evaluating NAC exposure in mCA or Triple I. Clinical outcomes, biomarkers, pharmacokinetics, and mechanistic pathways were synthesised narratively. Risk of bias was assessed using RoB 2, ROBINS-I, and SYRCLE tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten studies met the inclusion criteria, including five human and six translational animal studies. Human evidence involved approximately 143 mother\u2013infant dyads. NAC exposure was associated with preserved cerebrovascular coupling, improved delivery-room adaptation, reduced severe neonatal morbidity, and lower BPD rates without major safety concerns. Pharmacokinetic studies demonstrated rapid placental transfer and gestation-dependent neonatal clearance. Animal studies consistently showed reductions in inflammatory cytokines, oxidative stress, apoptosis, and microstructural brain injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NAC demonstrates biologically plausible neuroprotective potential in mCA and Triple I; however, the evidence remains preliminary due to small sample sizes and heterogeneous protocols. However, some studies showed no or negative effects. Large multicenter randomised trials with standardised dosing and long-term neurodevelopmental follow-up are needed before routine clinical implementation can be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1819220","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:26:26Z","timestamp":1788355586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Fetal and neonatal effects of N-acetylcysteine for maternal chorioamnionitis: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Fawzia Mohamed","family":"Elgharbawy","sequence":"first","affiliation":[{"name":"Neonatology Department, Faculty of Health Sciences, University of Southampton","place":["Southampton, United Kingdom"]},{"name":"Neonatal Intensive Care Unite (NICU), Women\u2019s Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC)","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A. A.","family":"Bayoumi","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unite (NICU), Women\u2019s Wellness and Research Center (WWRC), Hamad Medical Corporation (HMC)","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenni W.","family":"Ajele","sequence":"additional","affiliation":[{"name":"Faculty of Humanities, North-West University","place":["Potchefstroom, South Africa"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashir A.","family":"Lwaleed","sequence":"additional","affiliation":[{"name":"Neonatology Department, Faculty of Health Sciences, University of Southampton","place":["Southampton, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.clp.2010.02.003","article-title":"Diagnosis and management of clinical chorioamnionitis","volume":"37","author":"Tita","year":"2010","journal-title":"Clin Perinatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/GRF.0b013e31811ebef6","article-title":"The fetal inflammatory response syndrome","volume":"50","author":"Gotsch","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(14)70710-8","article-title":"Infection-induced inflammation and cerebral injury in preterm infants","volume":"14","author":"Strunk","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1067\/mob.2003.112","article-title":"Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation","volume":"188","author":"Buhimschi","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"CD004661","DOI":"10.1002\/14651858.CD004661.pub2","article-title":"Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus","volume":"1","author":"Doyle","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1016\/j.bbagen.2013.04.016","article-title":"The chemistry and biological activities of N-acetylcysteine","volume":"1830","author":"Samuni","year":"2013","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"B7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jpeds.2014.06.044","article-title":"Antenatal pharmacokinetics and placental transfer of N-acetylcysteine in chorioamnionitis for fetal neuroprotection","volume":"165","author":"Wiest","year":"2014","journal-title":"J Pediatr"},{"key":"B8","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1016\/j.vaccine.2019.05.030","article-title":"Chorioamnionitis: case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"37","author":"Kachikis","year":"2019","journal-title":"Vaccine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41390-020-01106-w","article-title":"Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial","volume":"89","author":"Buhimschi","year":"2021","journal-title":"Pediatr Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2015.09.076","article-title":"Fetal and neonatal effects of N-acetylcysteine when used for neuroprotection in maternal chorioamnionitis","volume":"168","author":"Jenkins","year":"2016","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/14767058.2010.528089","article-title":"N-acetylcysteine attenuates the maternal and fetal proinflammatory response to intrauterine LPS injection in an animal model for preterm birth and brain injury","volume":"24","author":"Chang","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.01.013","article-title":"Therapeutic N-acetylcysteine (Nac) following initiation of maternal inflammation attenuates long-term offspring cerebral injury, as evident in magnetic resonance imaging (MRI)","volume":"403","author":"Sharabi","year":"2019","journal-title":"Neuroscience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13629","DOI":"10.3390\/ijms222413629","article-title":"Maternal N-acetylcysteine prevents neonatal hypoxia-induced brain injury in a rat model","volume":"22","author":"Gutzeit","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0233612","DOI":"10.1371\/journal.pone.0233612","article-title":"Prophylactic antenatal N-Acetyl Cysteine administration combined with postnatal administration can decrease mortality and injury markers associated with necrotizing enterocolitis in a rat model","volume":"15","author":"Zmora","year":"2020","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000280385","article-title":"The anti-inflammatory agent N-Acetyl Cysteine exacerbates endotoxin-induced hypoxemia and hypotension and induces polycythemia in the ovine Fetus","volume":"98","author":"Probyn","year":"2010","journal-title":"Neonatology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/antiox10091344","article-title":"NAC And vitamin D improve CNS and plasma oxidative stress in neonatal HIE and are associated with favorable long-term outcomes","volume":"10","author":"Jenkins","year":"2021","journal-title":"Antioxidants"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/brainsci15121273","article-title":"Prenatal magnesium sulfate exposure is not associated with different neurodevelopmental outcomes by sex in extremely preterm infants","volume":"15","author":"DiNucci","year":"2025","journal-title":"Brain Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-026-05083-4","article-title":"Antenatal N-acetylcysteine supplementation in pregnant women with impending preterm birth: a prospective randomized placebo-controlled trial","author":"K\u00fcster","year":"2026","journal-title":"Pediatr Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12974-020-01984-1","article-title":"Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model","volume":"17","author":"Zhang","year":"2020","journal-title":"J Neuroinflammation"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1819220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:26:27Z","timestamp":1788355587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1819220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":20,"alternative-id":["10.3389\/fped.2026.1819220"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1819220","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"article-number":"1819220"}}